Evidence map›Paper›PMID 34817989›Full record

ArticleJournal of the American Chemical Society2021

Site-Specific Labeling of Endogenous Proteins Using CoLDR Chemistry.

Rambabu N Reddi, Adi Rogel, Efrat Resnick, Ronen Gabizon, Pragati Kishore Prasad, Neta Gurwicz, Haim Barr, Ziv Shulman, Nir London

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Modular Vinyl Phosphonamidates for Cysteine-Directed Protein Targeting.Journal of the American Chemical Society · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Covalent Proximity Inducers.Chemical reviews · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rambabu N ReddiDepartment of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel.
Adi RogelDepartment of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel.
Efrat ResnickDepartment of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel.
Ronen GabizonDepartment of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel.ORCID 0000-0002-3626-5073
Pragati Kishore PrasadDepartment of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel.
Neta GurwiczDepartment of Immunology, The Weizmann Institute of Science, Rehovot, 7610001, Israel.
Haim BarrWohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, The Weizmann Institute of Science, Rehovot, 7610001, Israel.
Ziv ShulmanDepartment of Immunology, The Weizmann Institute of Science, Rehovot, 7610001, Israel.
Nir LondonDepartment of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel.ORCID 0000-0003-2687-0699
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical modifications of native proteins can affect their stability, activity, interactions, localization, and more. However, there are few nongenetic methods for the installation of chemical modifications at a specific protein site in cells. Here we report a covalent ligand directed release (CoLDR) site-specific labeling strategy, which enables the installation of a variety of functional tags on a target protein while releasing the directing ligand. Using this approach, we were able to label various proteins such as BTK, K-Ras

Indexed as

LigandsAdenineAgammaglobulinaemia Tyrosine KinaseCatalytic DomainCoronavirus Papain-Like ProteasesFluorescent DyesHalf-LifeHumansPiperidinesProteolysisProto-Oncogene Proteins p21(ras)PyrimidinesSARS-CoV-2AdenineAgammaglobulinaemia Tyrosine KinaseCoronavirus Papain-Like ProteasesevobrutinibFluorescent DyesibrutinibKRAS protein, humanLigandspapain-like protease, SARS-CoV-2PiperidinesProto-Oncogene Proteins p21(ras)Pyrimidines

Identifiers

PMID34817989
PMCPMC8662641
OpenAlexW3216108850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.